TAP PHARMACEUTICALS INC has a total of 11 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, Ireland and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are THERAVAC PHARMACEUTICALS AB, NORDIC NANOVECTOR AS and SEATTLE GENETICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Ireland | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Norway | 1 | |
#8 | Portugal | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Haviv Fortuna | 8 |
#2 | Greer Jonathan | 7 |
#3 | Palabrica Christopher A | 4 |
#4 | Fitzpatrick Timothy D | 4 |
#5 | Killian Anthony | 1 |
#6 | Nichols Charles J | 1 |
#7 | Mort Nicholas A | 1 |
#8 | Swenson Rolf E | 1 |
Publication | Filing date | Title |
---|---|---|
US5534548A | Method of treating preeclampsia | |
US5413990A | N-terminus modified analogs of LHRH | |
US5140009A | Octapeptide LHRH antagonists | |
EP0400065A1 | Lhrh analog |